<?xml version="1.0" encoding="UTF-8"?>
<p>Prevention activities should be implemented and scaled up to effectively eliminate viral hepatitis transmission. A highly effective hepatitis B vaccine has been available since the 1980s, and early immunisation plus the distribution of hepatitis B immunoglobulin (HBIg) to at‐risk infants prevents perinatal transmission, as China has demonstrated.
 <xref rid="liv14222-bib-0058" ref-type="ref">58</xref> Harm reduction interventions, including NSPs and provision of OAT, cost‐effectively reduce primary and reinfection incidence among PWID.
 <xref rid="liv14222-bib-0059" ref-type="ref">59</xref>, 
 <xref rid="liv14222-bib-0060" ref-type="ref">60</xref>, 
 <xref rid="liv14222-bib-0061" ref-type="ref">61</xref> Iatrogenic transmission can be eliminated through routine screening of blood supply
 <xref rid="liv14222-bib-0062" ref-type="ref">62</xref> and implementation of safe infection practices (including reducing unnecessary injections, staff training and effective waste management),
 <xref rid="liv14222-bib-0063" ref-type="ref">63</xref> while simultaneously contributing to health systems strengthening.
 <xref rid="liv14222-bib-0004" ref-type="ref">4</xref>, 
 <xref rid="liv14222-bib-0064" ref-type="ref">64</xref>
</p>
